Skip to main content
main-content

01.03.2012 | Original Article | Ausgabe 3/2012

Supportive Care in Cancer 3/2012

Home care—a safe and attractive alternative to inpatient administration of intensive chemotherapies

Zeitschrift:
Supportive Care in Cancer > Ausgabe 3/2012
Autoren:
François Lüthi, Nadia Fucina, Nathalie Divorne, Brigitte Santos-Eggimann, Christine Currat-Zweifel, Patricia Rollier, Jean-Blaise Wasserfallen, Nicolas Ketterer, Serge Leyvraz

Abstract

Objective

The objective of this study was to evaluate feasibility, safety, perception, and costs of home care for the administration of intensive chemotherapies.

Methods

Patients receiving sequential chemotherapy in an inpatient setting, living within 30 km of the hospital, and having a relative to care for them were offered home care treatment. Chemotherapy was administered by a portable, programmable pump via an implantable catheter. The main endpoints were safety, patient’s quality of life [Functional Living Index—Cancer (FLIC)], satisfaction of patients and relatives, and costs.

Results

Two hundred days of home care were analysed, representing a total of 46 treatment cycles of intensive chemotherapy in 17 patients. Two cycles were complicated by technical problems that required hospitalisation for a total of 5 days. Three major medical complications (heart failure, angina pectoris, and major allergic reaction) could be managed at home. Grades 1 and 2 nausea and vomiting occurring in 36% of patients could be treated at home. FLIC scores remained constant throughout the study. All patients rated home care as very satisfactory or satisfactory. Patient benefits of home care included increased comfort and freedom. Relatives acknowledged better tolerance and less asthenia of the patient. Home care resulted in a 53% cost benefit compared to hospital treatment (€420 ± 120/day vs. €896 ± 165/day).

Conclusion

Administration of intensive chemotherapy regimens at home was feasible and safe. Quality of life was not affected; satisfaction of patients and relatives was very high. A psychosocial benefit was observed for patients and relatives. Furthermore, a cost–benefit of home care compared to hospital treatment was demonstrated.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 3/2012

Supportive Care in Cancer 3/2012 Zur Ausgabe
  1. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise